Back to search
FDAFDA · Food and drugs·Recall number D-0827-2018

0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10.

Published May 30, 2018 · Recall initiated: November 13, 2017

Summary

FDA records drug Class II recall D-0827-2018, published May 30, 2018 and initiated November 13, 2017. Recalling firm: Fresenius Medical Care Renal Therapies Group, LLC; Status: Terminated; Reported quantity: 25,356 1 liter bags; Lot: Lot # 17LU05005; Exp. 09/18 Part Number 060-10109. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Renal Therapies Group, LLC
Distributor
Product was distributed throughout the United States.
Lot
Lot # 17LU05005; Exp. 09/18 Part Number 060-10109
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection, USP, 1000 mL, Rx Only, Fresenius Medical Care North America, Waltham, MA 02451, NDC 49230-0300-10. recalled?

Yes. FDA published recall D-0827-2018 on May 30, 2018. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter